O
SNY icon

OrbiMed’s Sanofi SNY Stock Holding History

OrbiMed’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-68,400
Closed -$3.43M – 158
2019
Q4 		$3.43M Buy
+68,400
New +$3.2M 0.05% 111

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed's SNY Position: Q1 2020 in Review

OrbiMed sold out of Sanofi (SNY) in Q1 2020, closing a stake of 68,400 shares — an estimated $3.43M sold.

OrbiMed first reported a position in SNY in Q4 2019 and held it in 1 quarter. The position peaked at $3.43M in Q4 2019. 547 funds tracked by Wall St. Rank hold SNY as of Q1 2020.

  • OrbiMed reported no remaining Sanofi position as of Q1 2020 after selling out during the quarter.
  • OrbiMed sold 68,400 Sanofi shares in Q1 2020, an estimated $3.43M.
  • OrbiMed first reported a position in Sanofi in Q4 2019 and held it in 1 quarter.
  • OrbiMed's Sanofi position peaked at $3.43M in Q4 2019.
  • 547 funds tracked by Wall St. Rank held Sanofi as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.